Skip to Main Content

Author Details

Stefan Burdach
Technische Universitat Munchen
1981
284
49
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36892582The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.Clin Cancer Res2023
37843857Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.Clin Cancer Res2023
37217069A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.Cancer Lett2023
36892582The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.Clin Cancer Res2023
37843857Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.Clin Cancer Res2023
37217069A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.Cancer Lett2023
34586493Surgical treatment of a spontaneous spinal epidural hematoma under antithrombotic treatment of a multisystem inflammatory syndrome in children associated with SARS-COV-2.Childs Nerv Syst2022
35427190High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.J Clin Oncol2022
35619911No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.Front Oncol2022
36428578T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.Cancers (Basel)2022
36497479Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.Cancers (Basel)2022
36612267Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma.Cancers (Basel)2022
33908607MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.Blood2022
34980229Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.J Exp Clin Cancer Res2022
35267112Correction to: Precision medicine in pediatric oncology.Mol Cell Pediatr2022
34586493Surgical treatment of a spontaneous spinal epidural hematoma under antithrombotic treatment of a multisystem inflammatory syndrome in children associated with SARS-COV-2.Childs Nerv Syst2022
35427190High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma.J Clin Oncol2022
35619911No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.Front Oncol2022
36612267Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma.Cancers (Basel)2022
36428578T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.Cancers (Basel)2022
36497479Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.Cancers (Basel)2022
33908607MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.Blood2022
34980229Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.J Exp Clin Cancer Res2022
35267112Correction to: Precision medicine in pediatric oncology.Mol Cell Pediatr2022
34373590Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.Bone Marrow Transplant2021
33784678The Truncated Splice Variant of the Granulocyte-Macrophage-Colony-Stimulating Factor Receptor β- Chain in Peripheral Blood Serves as Severity Biomarker of Respiratory Failure in Newborns.Neonatology2021
34440851Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.Cells2021
34831294Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.Cells2021
34654445Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.J Exp Clin Cancer Res2021
34373590Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.Bone Marrow Transplant2021
34762643DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.PLoS Comput Biol2021
33784678The Truncated Splice Variant of the Granulocyte-Macrophage-Colony-Stimulating Factor Receptor β- Chain in Peripheral Blood Serves as Severity Biomarker of Respiratory Failure in Newborns.Neonatology2021
34440851Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.Cells2021
34762643DNA methylation-based classifier and gene expression signatures detect BRCAness in osteosarcoma.PLoS Comput Biol2021
34654445Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.J Exp Clin Cancer Res2021
34831294Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.Cells2021
31431735Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.Leukemia2020
31690822ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.Leukemia2020
32012890Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma.Cancers (Basel)2020
31928458Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.J Clin Oncol2020
31918587Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report.Int J Hyperthermia2020
33047515Sarcoma treatment in the era of molecular medicine.EMBO Mol Med2020
32748147Prospective evaluation of multitarget treatment of pediatric patients with helical intensity-modulated radiotherapy.Strahlenther Onkol2020
32610710MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo.Cells2020
31431735Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.Leukemia2020
31928458Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.J Clin Oncol2020
31690822ATM activity in T cells is critical for immune surveillance of lymphoma in vivo.Leukemia2020
32012890Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma.Cancers (Basel)2020
31918587Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report.Int J Hyperthermia2020
33047515Sarcoma treatment in the era of molecular medicine.EMBO Mol Med2020
  • 1 - 50 of 568

Recommended Authors

Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Sze Fai Yip
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 1
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 6
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 4
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 0
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 4
Shifra Ash
Ruth Rappaport Children's Hospital
Career Start Year 1988
Number of shared co-authors 4
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 0
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1986
Number of shared co-authors 1
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 8
Alan S Wayne
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 3
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 0
Toshio Kitamura
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 1
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Dietger Niederwieser
University of Leipzig
Career Start Year 1982
Number of shared co-authors 6
Bertram Opalka
University Hospital Essen.
Career Start Year 1982
Number of shared co-authors 2
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 1
Kenneth B Miller
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 1
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 3
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 1
Umihiko Sawada
Kasukabe Medical Center
Career Start Year 1978
Number of shared co-authors 0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 1
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Career Start Year 1976
Number of shared co-authors 2
Gerhard Fritsch
AUVA Trauma Hospital Salzburg
Career Start Year 1975
Number of shared co-authors 7
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 3
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 2
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1966
Number of shared co-authors 2

Collaborators

G??nther H S Richter
Children's Cancer Research Center
Co-authored papers 36
Uta Dirksen
University Hospital Essen, West German Cancer Center
Co-authored papers 33
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 26
Thomas Klingebiel
Co-authored papers 22
Michaela Nathrath
Co-authored papers 12
Ewa Koscielniak
Co-authored papers 10
Ruth Ladenstein
Children's Cancer Research Institute
Co-authored papers 10
Claudia Rossig
University Children's Hospital Muenster
Co-authored papers 9
Daniel Baumhoer
Co-authored papers 9
Stefan S Bielack
Co-authored papers 9
Markus Metzler
University Hospital Erlangen
Co-authored papers 7
Angelika Eggert
Co-authored papers 7
Christof M Kramm
Co-authored papers 7
Arndt Borkhardt
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Co-authored papers 7
Udo Kontny
Co-authored papers 6
Poul H Sorensen
British Columbia Cancer Research Centre
Co-authored papers 6
Hans-Stefan Hofmann
Co-authored papers 6
Charlotte M Niemeyer
Co-authored papers 5
Andreas E Kulozik
Co-authored papers 5
Simone Fulda
Co-authored papers 5
Frank Berthold
Co-authored papers 4
Heinrich Kovar
St. Anna Children's Cancer Research Institute (CCRI), Medical University Vienna
Co-authored papers 4
Michael C Frühwald
Co-authored papers 4
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 4
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 3
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Co-authored papers 3
Patrick J Grohar
Children's Hospital of Philadelphia.
Co-authored papers 3
Elizabeth R Lawlor
Seattle Children's Research Institute
Co-authored papers 3
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 3
Franck Tirode
Cancer Center of Lyon
Co-authored papers 3
Release 1.2